Komori
Jmdc (4483) · InitiativeAdvanced

Research and development in severe disease prevention, polypharmacy, pediatric medicine, and health and productivity management

First written in FY2020. 5 of 6 entries say "Advanced", first in FY2022. Latest entry: 2026-06-24.

6entries
7years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2020AdvancedFY2022 – 2026-06-242020: 120202021: 020212022: 120222023: 020232024: 020242025: 020252026: 42026
Same theme, other companies
Research on Preventing Disease Progression and Predicting Healthcare Needs Using Health Big DataA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  2. FY2022AdvancedAnnual report

    「Launch of the “Medical Collaboration Program for Dialysis and Ischemic Heart Disease Prevention” using AI to predict disease onset」

    Expanded research and development themes, including prevention of disease severity, medical cost forecasting, the risk of severe COVID-19, child statistics and AI-based disease-onset prediction, into the service provision and demonstration stages.
  3. FY2020First statedAnnual report

    「We are advancing development focused on preventing extreme disease severity, addressing polypharmacy, Big Data for Children and corporate health management.」

    Lists individual interventions, pediatric healthcare and corporate health management among the research and development themes in the health big data field.
Moved together

"Healthcare Big Data Analytics, PHR and Data Utilisation" moved the same way as this thread, in the same document, in 5 of its 6 moves.

522222★123456
  1. ★This thread
  2. 1Healthcare Big Data Analytics, PHR and Data Utilisation5×
  3. 2Expansion of Health Insurance Societies, PeP Up and Data Utilization for Companies2×
  4. 3Expansion of Contracted Radiologists and Contracted Medical Institutions2×
  5. 4Revenue and earnings growth underpinned by three businesses2×
  6. 5Expansion and enhancement of services for medical institutions2×
  7. 6Strengthening the Health Data and Overseas Businesses through a Capital and Business Alliance with OMRON2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Jmdc's next results are scheduled for 2026-11-05. Read the earnings preview It last moved in the Other Disclosures of 2026-06-24: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Research and development in severe disease prevention, polypharmacy, pediatric medicine, and health and productivity management | JMDC Inc. (4483) | Komori